NEOXCEL
Live / Applied — Non-final action mailed (as of 17 Mar 2026)
What this means for you
Not registered yet, but its 21 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99454482
- Mark type
- Stylized text
- Filed
- 21 Oct 2025
- Attorney of record
- Matthew T. Kramer
Goods and services
- Class 005 — Pharmaceuticals: Tissue-based products, namely, biological tissue grafts for use in dental, medical, and surgical procedures and applications; Pharmaceutical preparations and substances, namely, biological tissue grafts for use in regenerative medicine, wound repair, and surgical repair; Wound healing system, namely, biological tissue grafting materials for use in regenerative medicine, wound repair, and surgical repair; Biological tissue grafts used in combination with surgical implants for use in soft tissue reconstruction; Surgical implants made of biological materials for use in soft tissue
- Class 010 — Medical apparatus: Surgical apparatus and instruments for medical and dental use; Surgical implants made of synthetic materials for use in soft tissue; Medical devices, namely templates for use in creating tissue grafts; Synthetic tissue grafting materials for use in dental, medical, and surgical procedures and applications; Pharmaceutical preparations and substances, namely, synthetic tissue grafting materials for use in regenerative medicine, wound repair, and surgical repair; Surgical sutures, namely, bioabsorbable surgical sutures
Owner
- CellTherX Corp, Dallas, TX, US
Prosecution history
- 17 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Mar 2026 — NON-FINAL ACTION E-MAILED
- 17 Mar 2026 — NON-FINAL ACTION WRITTEN
- 07 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Oct 2025 — NEW APPLICATION ENTERED